- Safety and Efficacy of MK-5172 + MK-8742 in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052)Condition: Hepatitis C Virus
Interventions: Drug: MK-5172; Drug: MK-8742; Drug: Placebo to MK-5172; Drug: Placebo to MK-8742
Sponsor: Merck Sharp & Dohme Corp.
Recruiting - verified July 2014
- Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComorbiditiesCondition: Cardiovascular Disease
Interventions: Drug: Febuxostat; Drug: Allopurinol
Sponsors: Takeda; Teijin
Recruiting - verified June 2014